Biovail To Market Tramadol Under Ortho’s Ultram Brand
This article was originally published in The Pink Sheet Daily
Executive Summary
The partnership for tramadol extended-release and once-daily formulations will grant Biovail use of the Ultram trade name.
You may also be interested in...
Labopharm Appeals Tramadol “Approvable” Letter
The firm also submits a complete response to FDA with additional analysis of existing data.
Labopharm Appeals Tramadol “Approvable” Letter
The firm also submits a complete response to FDA with additional analysis of existing data.
Ouch: Cipher Maintains Phase III Trial Failure Of Tramadol Will Not Impact NDA
Ontario drug maker may have to contend with two other competitors in the synthetic opioid space.